The Swiss League Against Epilepsy is helping to increase knowledge about epilepsy with its annual research grant of CHF 25,000. This year, applications are invited for two further awards: the Alfred Hauptmann Award totals EUR 10,000 and the Prize for Best Dissertation in the field of epileptology is also on offer. The application deadline for all awards is 31 December 2018.
(Zurich) The Research Recognition Award from the Swiss League Against Epilepsy totals CHF 25,000. It is awarded annually to researchers working in Switzerland as start-up funding for larger research projects. Applications from researchers carrying out studies on causes of and therapies for epilepsies are especially welcome.
The Alfred Hauptmann Award is bestowed together with the German and Austrian epileptology associations to individuals or working groups for the best experimental or clinical research in the field of epileptology in German‐speaking countries. It is awarded every two years and totals EUR 10,000. Since 2009, UCB has donated the prize money for this award.
The award is named after the German neurologist Alfred Hauptmann, who discovered the anticonvulsant efficacy of phenobarbital in 1912 and had to emigrate from Germany in 1939 because of his Jewish origins.
Every three years, the author of the best doctoral thesis in the field of epileptology from a Swiss university is awarded the Prize for Best Dissertation worth CHF 1,000. Applications are not restricted to the field of medicine and are equally welcome from those studying related disciplines such as psychology or pharmacology whose work deals with epilepsy.
All three awards will be presented at the Epilepsy League’s annual conference. Co-organized with the German and Austrian chapters of the International League Against Epilepsy, it will take place in Basel on 8 to 11 May 2019.
Bidding for all three awards is open until 31 December 2018.